- Home
- EYEN vs ITRG Comparison
EYEN vs ITRG Comparison
Compare EYEN & ITRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYEN
- ITRG
- Stock Information
- Founded
- EYEN 2014
- ITRG 1997
- Country
- EYEN United States
- ITRG Canada
- Employees
- EYEN N/A
- ITRG N/A
- Industry
- EYEN Biotechnology: Pharmaceutical Preparations
- ITRG Precious Metals
- Sector
- EYEN Health Care
- ITRG Basic Materials
- Exchange
- EYEN Nasdaq
- ITRG Nasdaq
- Market Cap
- EYEN 38.2M
- ITRG 84.2M
- IPO Year
- EYEN 2018
- ITRG N/A
- Fundamental
- Price
- EYEN $0.55
- ITRG $1.20
- Analyst Decision
- EYEN Strong Buy
- ITRG Strong Buy
- Analyst Count
- EYEN 2
- ITRG 1
- Target Price
- EYEN $12.00
- ITRG $3.75
- AVG Volume (30 Days)
- EYEN 879.0K
- ITRG 259.4K
- Earning Date
- EYEN 11-11-2024
- ITRG 11-12-2024
- Dividend Yield
- EYEN N/A
- ITRG N/A
- EPS Growth
- EYEN N/A
- ITRG N/A
- EPS
- EYEN N/A
- ITRG N/A
- Revenue
- EYEN $31,405.00
- ITRG N/A
- Revenue This Year
- EYEN $50,309.30
- ITRG N/A
- Revenue Next Year
- EYEN $421.63
- ITRG $360.53
- P/E Ratio
- EYEN N/A
- ITRG N/A
- Revenue Growth
- EYEN N/A
- ITRG N/A
- 52 Week Low
- EYEN $0.37
- ITRG $0.64
- 52 Week High
- EYEN $2.57
- ITRG $1.28
- Technical
- Relative Strength Index (RSI)
- EYEN 52.60
- ITRG 66.49
- Support Level
- EYEN $0.52
- ITRG $0.95
- Resistance Level
- EYEN $0.59
- ITRG $1.28
- Average True Range (ATR)
- EYEN 0.05
- ITRG 0.07
- MACD
- EYEN 0.01
- ITRG 0.01
- Stochastic Oscillator
- EYEN 66.45
- ITRG 77.27
About EYEN Eyenovia Inc.
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.